Related references
Note: Only part of the references are listed.The IPD-IMGT/HLA Database
Dominic J. Barker et al.
NUCLEIC ACIDS RESEARCH (2023)
The CD56-CD16+NK cell subset in chronic infections
Alexander T. H. Cocker et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2023)
Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
Ana C. Maretti-Mira et al.
FRONTIERS IN IMMUNOLOGY (2023)
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant
Jeffrey J. Bednarski et al.
BLOOD (2022)
Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy
Lara Herrera et al.
IMMUNOLOGY (2022)
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
Jeffrey S. Miller et al.
NATURE MEDICINE (2022)
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
Melissa M. Berrien-Elliott et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients
Jose L. Casado et al.
VIRUSES-BASEL (2022)
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
Jocelyn T. Kim et al.
NATURE COMMUNICATIONS (2022)
Deep Phenotypic Analysis of Blood and Lymphoid T and NK Cells From HIV plus Controllers and ART-Suppressed Individuals
Ashley F. George et al.
FRONTIERS IN IMMUNOLOGY (2022)
Immune Dysfunctions of CD56neg NK Cells Are Associated With HIV-1 Disease Progression
Wen-Jing Cao et al.
FRONTIERS IN IMMUNOLOGY (2022)
Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients
An-Liang Guo et al.
EBIOMEDICINE (2022)
Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients
Xiaohui Zhang et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)
SARS-CoV-2 pathogenesis
Mart M. Lamers et al.
NATURE REVIEWS MICROBIOLOGY (2022)
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19
Ting Lu et al.
NATURE COMMUNICATIONS (2022)
Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers
Miguel Galan et al.
FRONTIERS IN IMMUNOLOGY (2022)
From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement
Lois Coenon et al.
FRONTIERS IN IMMUNOLOGY (2022)
Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza
Demi Brownlie et al.
FRONTIERS IN IMMUNOLOGY (2022)
Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
Inigo Terren et al.
FRONTIERS IN IMMUNOLOGY (2022)
Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer
Kathleen Ducoin et al.
ONCOIMMUNOLOGY (2022)
CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire
Norfarazieda Hassan et al.
FRONTIERS IN IMMUNOLOGY (2022)
Age-dependent NK cell dysfunctions in severe COVID-19 patients
Cinzia Fionda et al.
FRONTIERS IN IMMUNOLOGY (2022)
An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets
Jaekeun Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C
Sarah Vollmers et al.
FRONTIERS IN IMMUNOLOGY (2022)
Implications of NKG2A in immunity and immune-mediated diseases
Xiaotong Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer
Miriam Franklin et al.
FRONTIERS IN IMMUNOLOGY (2022)
Dynamic Evaluation of Natural Killer Cells Subpopulations in COVID-19 Patients
Adina Hutanu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagers
Sheena Pinto et al.
TRENDS IN IMMUNOLOGY (2022)
CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression
Alexander T. H. Cocker et al.
FRONTIERS IN IMMUNOLOGY (2022)
Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
Hongwen Li et al.
FRONTIERS IN IMMUNOLOGY (2022)
Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates
Bert Malengier-Devlies et al.
FRONTIERS IN IMMUNOLOGY (2022)
Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo
Sadia Samer et al.
JCI INSIGHT (2022)
Human NK cells confer protection against HIV-1 infection in humanized mice
Can M. Sungur et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Expansion, persistence, and efficacy of donor memory- like NK cells infused for posttransplant relapse
Roman M. Shapiro et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients
Xiaohui Zhang et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)
Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients
Dalila Mele et al.
HEPATOLOGY (2021)
Unique immunological profile in patients with COVID-19
Stefania Varchetta et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
TIM3+TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
Levi Hoste et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Recent progress in TGF-β inhibitors for cancer therapy
Cheng-Yi Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
Mario Witkowski et al.
NATURE (2021)
Natural Killer Cells: From Innate to Adaptive Features
Adriana M. Mujal et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers
Zhi Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Viral infection modulates Qa-1b in infected and bystander cells to properly direct NK cell killing
Maria Ferez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Phenotypic and Functional Characteristics of a Novel Influenza Virus Hemagglutinin-Specific Memory NK Cell
Jian Zheng et al.
JOURNAL OF VIROLOGY (2021)
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
Parisa Shiri Aghbash et al.
LIFE SCIENCES (2021)
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity
Federica Bozzano et al.
PLOS PATHOGENS (2021)
Bispecific Antibodies: From Research to Clinical Application
Jiabing Ma et al.
FRONTIERS IN IMMUNOLOGY (2021)
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
Karrune Woan et al.
CELL STEM CELL (2021)
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments
Olivier Demaria et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Abnormality in the NK-cell population is prolonged in severe COVID-19 patients
Galam Leem et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy
Shee Kwan Phung et al.
MOLECULAR DIAGNOSIS & THERAPY (2021)
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection
Roberto Littera et al.
PLOS ONE (2021)
Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
Matthijs Meijers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children
Noam D. Beckmann et al.
NATURE COMMUNICATIONS (2021)
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Jinhua Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
Lorena Vigon et al.
FRONTIERS IN IMMUNOLOGY (2021)
Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients
Lea Dubreuil et al.
CANCERS (2021)
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Cristina Capuano et al.
CANCERS (2021)
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
Wan-Chen Hsieh et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Dynamic blood single-cell immune responses in patients with COVID-19
Lulin Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use
Matthew D. Blunt et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2020)
PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity
Jacqueline Moebius et al.
INFECTION AND IMMUNITY (2020)
Broadly neutralizing antibodies for the treatment and prevention of HIV infection
Marina Caskey
CURRENT OPINION IN HIV AND AIDS (2020)
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
Lillian B. Cohn et al.
CELL HOST & MICROBE (2020)
Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics
Heliang Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage
Hao Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan et al.
FRONTIERS IN IMMUNOLOGY (2020)
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques
Gabriela M. Webb et al.
PLoS Pathogens (2020)
FcγR Binding and ADCC Activity of Human IgG Allotypes
Steven W. de Taeye et al.
FRONTIERS IN IMMUNOLOGY (2020)
MICA*012:01Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer
Weifeng Ding et al.
FRONTIERS IN GENETICS (2020)
A Universal CAR-NK Cell Targeting Various Epitopes of HIV-1 gp160
Rebecca M. Lim et al.
ACS CHEMICAL BIOLOGY (2020)
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
Yu-Qing Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Kin Man Au et al.
SCIENCE ADVANCES (2020)
Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance
Elaheh Hashemi et al.
CANCERS (2020)
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Alessio Mazzoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents
Ahmed Yaqinuddin et al.
MEDICAL HYPOTHESES (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential
Yujie Jiang et al.
CLINICAL IMMUNOLOGY (2020)
The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection
Kristen E. Pauken et al.
CELL REPORTS (2020)
Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therapy
Leilei Ai et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease
Mingyue Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing
Gang Xu et al.
CELL DISCOVERY (2020)
Natural killer cell immunotypes related to COVID-19 disease severity
Christopher Maucourant et al.
SCIENCE IMMUNOLOGY (2020)
Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
Samantha Barnes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Centromeric KIR AA Individuals Harbor Particular KIR Alleles Conferring Beneficial NK Cell Features with Implications in Haplo-Identical Hematopoietic Stem Cell Transplantation
Lea Dubreuil et al.
CANCERS (2020)
Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis
Francesca Velotti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Potential approaches to combat COVID-19: a mini-review
Zainab Sarwar et al.
MOLECULAR BIOLOGY REPORTS (2020)
The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
Linda Quatrini et al.
CANCERS (2020)
An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes
Adam S. Dingens et al.
IMMUNITY (2019)
NK cells in treated HIV-infected children display altered phenotype and function
Sanjana Mahapatra et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Memory and CAR-NK cell-based novel approaches for HIV vaccination and eradication
Abdulbaset Mazarzaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Aberrant natural killer (NK) cell activation and dysfunction among ART treated HIV-infected adults in an African cohort
Rose Nabatanzi et al.
CLINICAL IMMUNOLOGY (2019)
DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
Loredana Cifaldi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Chao Zhang et al.
NATURE COMMUNICATIONS (2019)
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Daniela Pende et al.
FRONTIERS IN IMMUNOLOGY (2019)
Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells
Marlena Scharenberg et al.
FRONTIERS IN IMMUNOLOGY (2019)
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function
Helen R. Wagstaffe et al.
JOURNAL OF IMMUNOLOGY (2019)
CD56-CD16+ NK cells from HIV-infected individuals negatively regulate IFN-γ production by autologous CD8+ T cells
Meichen Ma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
Martine Bagot et al.
LANCET ONCOLOGY (2019)
TGF-β1 increases viral burden and promotes HIV-1 latency in primary differentiated human bronchial epithelial cells
S. Chinnapaiyan et al.
SCIENTIFIC REPORTS (2019)
FcγRIIIa receptor polymorphism influences NK cell mediated ADCC activity against HIV
Sneha Pramod Talathi et al.
BMC INFECTIOUS DISEASES (2019)
IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
Simone I. Richardson et al.
PLOS PATHOGENS (2019)
Influenza virus-related critical illness: pathophysiology and epidemiology
Andre C. Kalil et al.
CRITICAL CARE (2019)
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives
Cristiana Lo Nigro et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense
Vincent Larochette et al.
FRONTIERS IN IMMUNOLOGY (2019)
KIR and HLA-C Genetic Polymorphisms Influence Plasma IP-10 Concentration in Antiretroviral Therapy-Naive HIV-Infected Adult Zimbabweans
Kudakwashe Mhandire et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2019)
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment
Amy L. Ellis-Connell et al.
JOURNAL OF VIROLOGY (2018)
IL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection
Yongjun Jiang et al.
BMC INFECTIOUS DISEASES (2018)
IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production
Helen R. Wagstaffe et al.
JOURNAL OF IMMUNOLOGY (2018)
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo
Carolina Garrido et al.
JOURNAL OF VIROLOGY (2018)
KLRD1-expressing natural killer cells predict influenza susceptibility
Erika Bongen et al.
GENOME MEDICINE (2018)
NKG2D and Its Ligands: One for All, All for One
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2018)
Natural Killer Cell Recruitment to the Lung During Influenza A Virus Infection Is Dependent on CXCR3, CCR5, and Virus Exposure Dose
Lindsey E. Carlin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus
Grace E. Cooper et al.
FRONTIERS IN IMMUNOLOGY (2018)
HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance
Mario Frias et al.
SCIENTIFIC REPORTS (2018)
HLA-C downregulation by HIV-1 adapts to host HLA genotype
Nathaniel D. Bechtel et al.
PLOS PATHOGENS (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies
Lizdany Florez-Alvarez et al.
FRONTIERS IN IMMUNOLOGY (2018)
Uncompromised NK cell activation is essentia for virus-specific CTL activity during acute influenza virus infection
Yuan Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells
Erica Giuliani et al.
IMMUNOLOGY LETTERS (2017)
NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib
Ryujiro Hara et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
Martin Rao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression
Patrick Dierks et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
NK cells in self-limited HCV infection exhibit a more extensively differentiated, but not memory-like, repertoire
R. A. de Groen et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Alterations of the NK cell pool in HIV/HCV co-infection
Dominik J. Kaczmarek et al.
PLOS ONE (2017)
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
Zachary B. Davis et al.
SEMINARS IN IMMUNOLOGY (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Developmental and Functional Control of Natural Killer Cells by Cytokines
Yang Wu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Avian influenza virus directly infects human natural killer cells and inhibits cell activity
Huawei Mao et al.
VIROLOGICA SINICA (2017)
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
Wei Li et al.
SCIENTIFIC REPORTS (2017)
NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147
Francoise Gondois-Rey et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
Loredana Ruggeri et al.
HAEMATOLOGICA (2016)
Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment
Michelle Spaan et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
Loredana Ruggeri et al.
HAEMATOLOGICA (2016)
CD57 in human natural killer cells and T-lymphocytes
Hassen Kared et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
HIV-1 Vpu Mediates HLA-C Downregulation
Richard Apps et al.
CELL HOST & MICROBE (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma
Mattias Carlsten et al.
CLINICAL CANCER RESEARCH (2016)
Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans
Charles Bayard et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
The influence of NK cell-mediated ADCC: Structure and expression of the CD16 molecule differ among FcγRIIIa-V158F genotypes in healthy Japanese subjects
Wataru Oboshi et al.
HUMAN IMMUNOLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Accumulation of Intrahepatic TNF--Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection
Isabelle Nel et al.
MEDICINE (2016)
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Ching-Lan Lu et al.
SCIENCE (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Immune Adaptation to Environmental Influence: The Case of NK Cells and HCMV
Alexander Roelle et al.
TRENDS IN IMMUNOLOGY (2016)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi-Ferchiou et al.
ONCOTARGET (2016)
TriKEs and BiKEs join CARs on the cancer immunotherapy highway
Szun Szun Tay et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells
Zachary B. Davis et al.
PLOS PATHOGENS (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
A Novel HIV Envelope Bi-Specific Killer Engager Enhances Natural Killer Cell Mediated ADCC Responses Against HIV-Infected Cells
Zachary B. Davis et al.
BLOOD (2016)
The HLA-C*04:01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression
Alex Olvera et al.
AIDS (2015)
Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age
Carmen Campos et al.
BIOGERONTOLOGY (2015)
Natural Killer Cell Adoptive Transfer Therapy Exploiting the First Line of Defense Against Cancer
Zachary B. Davis et al.
CANCER JOURNAL (2015)
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Don M. Benson et al.
CLINICAL CANCER RESEARCH (2015)
Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
Heinrich Schlums et al.
IMMUNITY (2015)
HIV-Specific ADCC Improves After Antiretroviral Therapy and Correlates With Normalization of the NK Cell Phenotype
Sanne S. Jensen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells
Julia A. M. Sung et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
NK-cells are involved in thymic atrophy induced by influenza A virus infection
Xuefeng Duan et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Blimp-1, an Intrinsic Factor that Represses HIV-1 Proviral Transcription in Memory CD4+ T Cells
Katarzyna Kaczmarek Michaels et al.
JOURNAL OF IMMUNOLOGY (2015)
Antibody-Mediated Response of NKG2Cbright NK Cells against Human Cytomegalovirus
Marcel Costa-Garcia et al.
JOURNAL OF IMMUNOLOGY (2015)
Human Cytokine-Induced Memory-Like Natural Killer Cells
Melissa M. Berrien-Elliott et al.
JOURNAL OF INNATE IMMUNITY (2015)
Antigen-specific NK cell memory in rhesus macaques
R. Keith Reeves et al.
NATURE IMMUNOLOGY (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+Natural Killer Cells: Data from an Observational Cohort in South Africa
Angelique Hoelzemer et al.
PLOS MEDICINE (2015)
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
Cariad Chester et al.
FRONTIERS IN IMMUNOLOGY (2015)
HIV infection
Steven G. Deeks et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells
Charline Miot et al.
GUT (2015)
Bispecific T-cell engagers for cancer immunotherapy
Amelia M. Huehls et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Influenza Vaccine Induces Intracellular Immune Memory of Human NK Cells
Yaling Dou et al.
PLOS ONE (2015)
A phase 1 dose-escalation study of IPH2102 (lirilumab, BMS-986015, LIRI), a fully human anti KIR monoclonal antibody (mAb) in patients (pts) with various hematologic (HEM) or solid malignancies (SOL).
Norbert Vey et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Understanding of molecular mechanisms in natural killer cell therapy
Suk Ran Yoon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
A replication study confirms the association of GWAS-identified SNPs at MICB and PLCE1in Thai patients with dengue shock syndrome
Tran Ngoc Dang et al.
BMC Medical Genetics (2014)
Perforin: an important player in immune response
Iwona Osinska et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
The Natural Killer Cell Interferon-Gamma Response to Bacteria Is Diminished in Untreated HIV-1 Infection and Defects Persist Despite Viral Suppression
Stephanie M. Dillon et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S. Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cutting Edge: NKG2ChiCD57+ NK Cells Respond Specifically to Acute Infection with Cytomegalovirus and Not Epstein-Barr Virus
Deborah W. Hendricks et al.
JOURNAL OF IMMUNOLOGY (2014)
Compromised Function of Natural Killer Cells in Acute and Chronic Viral Hepatitis
Sebastian Lunemann et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains
Weizao Chen et al.
JOURNAL OF VIROLOGY (2014)
KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function
Aimee M. Merino et al.
PLOS ONE (2014)
Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver
Cormac Cosgrove et al.
PLOS ONE (2014)
Extracellular HCV-Core Protein Induces an Immature Regulatory Phenotype in NK Cells: Implications for Outcome of Acute Infection
Lucy Golden-Mason et al.
PLOS ONE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Expression of Chimeric Receptor CD4ζ by Natural Killer Cells Derived from Human Pluripotent Stem Cells Improves In Vitro Activity but Does Not Enhance Suppression of HIV Infection In Vivo
Zhenya Ni et al.
STEM CELLS (2014)
Correction: Copy Number Variation of KIR Genes Influences HIV-1 Control
Kimberly Pelak et al.
PLOS BIOLOGY (2014)
PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
Alexander W. MacFarlane et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Influenza Virus Infection but Not H1N1 Influenza Virus Immunization Is Associated with Changes in Peripheral Blood NK Cell Subset Levels
A. Juarez-Reyes et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
NK cells exacerbate the pathology of influenza virus infection in mice
Gang Zhou et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Blocking the Natural Killer Cell Inhibitory Receptor NKG2A Increases Activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in Mice
Fenglei Li et al.
GASTROENTEROLOGY (2013)
Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection
Leia H. Wren et al.
IMMUNOLOGY (2013)
CMV induces rapid NK cell maturation in HSCT recipients
Mariella Della Chiesa et al.
IMMUNOLOGY LETTERS (2013)
Natural killer cell deficiency
Jordan S. Orange
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4(+) T Cell Levels in Humanized Mice
Brent E. Palmer et al.
JOURNAL OF IMMUNOLOGY (2013)
Amplified NKG2C+ NK Cells in Cytomegalovirus (CMV) Infection Preferentially Express Killer Cell Ig-like Receptor 2DL: Functional Impact in Controlling CMV-Infected Dendritic Cells
Zakia Djaoud et al.
JOURNAL OF IMMUNOLOGY (2013)
Local Blockade of Epithelial PDL-1 in the Airways Enhances T Cell Function and Viral Clearance during Influenza Virus Infection
Beth McNally et al.
JOURNAL OF VIROLOGY (2013)
CD56negCD16+ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
Jeffrey M. Milush et al.
RETROVIROLOGY (2013)
Location and cellular stages of natural killer cell development
Jianhua Yu et al.
TRENDS IN IMMUNOLOGY (2013)
Differential lung NK cell responses in avian influenza virus infected chickens correlate with pathogenicity
Christine A. Jansen et al.
SCIENTIFIC REPORTS (2013)
Epigenetic regulation of NK cell differentiation and effector functions
Frank Cichocki et al.
FRONTIERS IN IMMUNOLOGY (2013)
High frequencies of CD158b+ NK cells are associated with persistent hepatitis C virus infections
Hui-Fan Ji et al.
ANNALS OF HEPATOLOGY (2013)
The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
Nicos Karasavvas et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
Bree Foley et al.
BLOOD (2012)
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
Don M. Benson et al.
BLOOD (2012)
Cytokine activation induces human memory-like NK cells
Rizwan Romee et al.
BLOOD (2012)
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients
Vivien Beziat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation
Gregor F. Lichtfuss et al.
JOURNAL OF IMMUNOLOGY (2012)
Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
Bree Foley et al.
JOURNAL OF IMMUNOLOGY (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
Jason Grebely et al.
LANCET INFECTIOUS DISEASES (2012)
Altered distribution of mucosal NK cells during HIV infection
M. Sips et al.
MUCOSAL IMMUNOLOGY (2012)
The structural biology of HIV-1: mechanistic and therapeutic insights
Alan Engelman et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Severe Pandemic H1N1 2009 Infection Is Associated with Transient NK and T Deficiency and Aberrant CD8 Responses
Annette Fox et al.
PLOS ONE (2012)
IL-15 Participates in the Respiratory Innate Immune Response to Influenza Virus Infection
Katherine C. Verbist et al.
PLOS ONE (2012)
Loss of CCR7 Expression on CD56bright NK Cells Is Associated with a CD56dimCD16+ NK Cell-Like Phenotype and Correlates with HIV Viral Load
Henoch S. Hong et al.
PLOS ONE (2012)
Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody
Daniela Tudor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
PD-1 Expression on Natural Killer Cells and CD8+ T Cells During Chronic HIV-1 Infection
Sonia Norris et al.
VIRAL IMMUNOLOGY (2012)
HIV: Cell Binding and Entry
Craig B. Wilen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge
Michael D. Alpert et al.
PLOS PATHOGENS (2012)
Evolving role of 2B4/CD244 in T and NK cell responses during virus infection
Stephen N. Waggoner et al.
FRONTIERS IN IMMUNOLOGY (2012)
The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life
Jennifer A. Slyker et al.
FRONTIERS IN IMMUNOLOGY (2012)
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
Gamze Isitman et al.
ADVANCES IN VIROLOGY (2012)
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
Paul A. Moore et al.
BLOOD (2011)
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
Don M. Benson et al.
BLOOD (2011)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control
Rutger Luteijn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza
Stephanie Jost et al.
IMMUNOLOGY (2011)
Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+NK cells in acute HCV infection may predict viral clearance
Galit Alter et al.
JOURNAL OF HEPATOLOGY (2011)
Engineered Single Human CD4 Domains as Potent HIV-1 Inhibitors and Components of Vaccine Immunogens
Weizao Chen et al.
JOURNAL OF VIROLOGY (2011)
HIV-1 adaptation to NK-cell-mediated immune pressure
Galit Alter et al.
NATURE (2011)
Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1
Chiea Chuen Khor et al.
NATURE GENETICS (2011)
Changes in Cytokine Levels and NK Cell Activation Associated with Influenza
Stephanie Jost et al.
PLOS ONE (2011)
Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-γ on activation
Andrea De Maria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
Sandra Lopez-Verges et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human cell types important for Hepatitis C Virus replication in vivo and in vitro. Old assertions and current evidence
Dennis Revie et al.
VIROLOGY JOURNAL (2011)
An overview of HCV molecular biology, replication and immune responses
Usman A. Ashfaq et al.
VIROLOGY JOURNAL (2011)
Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment
Omar Dessouki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing
Jonathan Richard et al.
BLOOD (2010)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Eleni G. Iliopoulou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Degranulation of Natural Killer Cells Following Interaction with HIV-1-Infected Cells Is Hindered by Downmodulation of NTB-A by Vpu
Ankur H. Shah et al.
CELL HOST & MICROBE (2010)
Association of NKG2A with treatment for chronic hepatitis C virus infection
R. J. Harrison et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
Paola Fisicaro et al.
GASTROENTEROLOGY (2010)
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus
Barbara Amadei et al.
GASTROENTEROLOGY (2010)
Increased Natural Killer Cell Cytotoxicity and NKp30 Expression Protects Against Hepatitis C Virus Infection in High-Risk Individuals and Inhibits Replication In Vitro
Lucy Golden-Mason et al.
HEPATOLOGY (2010)
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection
Nadia Wauquier et al.
IMMUNOGENETICS (2010)
Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens
Charles Cunningham et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Natural Killer Cells That Respond to Human Immunodeficiency Virus Type 1 (HIV-1) Peptides Are Associated with Control of HIV-1 Infection
Caroline T. Tiemessen et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV Infection Is Associated with a Preferential Decline in Less-Differentiated CD56dim CD16+ NK Cells
Henoch S. Hong et al.
JOURNAL OF VIROLOGY (2010)
Differential Activation of NK Cells by Influenza A Pseudotype H5N1 and 1918 and 2009 Pandemic H1N1 Viruses
Ning Du et al.
JOURNAL OF VIROLOGY (2010)
NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
Vivien Beziat et al.
PLOS ONE (2010)
IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells
Hiroki Ishikawa et al.
VIROLOGY (2010)
Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma
Shigehiro Tamaki et al.
CLINICAL IMMUNOLOGY (2009)
CD56bright natural killer (NK) cells: an important NK cell subset
Aurelie Poli et al.
IMMUNOLOGY (2009)
Natural killer cell cytotoxicity: how do they pull the trigger?
Nicola J. Topham et al.
IMMUNOLOGY (2009)
The functional impairment of natural killer cells during influenza virus infection
Hailong Guo et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Nicholas D. Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cuttine Edge: Unusual NK Cell Responses to HIV-1 Peptides Are Associated with Protection against Maternal-Infant Transmission of HIV-1
Caroline T. Tiemessen et al.
JOURNAL OF IMMUNOLOGY (2009)
Increased Frequency of CD56(Bright) NK-Cells, CD3(-)CD16(+)CD56(-) NK-Cells and Activated CD4(+)T-Cells or B-Cells in Parallel With CD4(+)CDC25(High) T-Cells Control Potentially Viremia in Blood Donors With HCV
Maria Alice Sant'Anna Zarife et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Influenza Virus Directly Infects Human Natural Killer Cells and Induces Cell Apoptosis
Huawei Mao et al.
JOURNAL OF VIROLOGY (2009)
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Vijayakumar Velu et al.
NATURE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MHC class I chain-related gene A transmembrane polymorphism in Spanish women with breast cancer
R. Lavado-Valenzuela et al.
TISSUE ANTIGENS (2009)
HIV-1 Vpr Triggers Natural Killer Cell-Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response
Jeffrey Ward et al.
PLOS PATHOGENS (2009)
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
David H. Raulet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure
L. Golden-Mason et al.
GUT (2008)
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus
Brian R. Long et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
Galit Alter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients
Shigehiro Tamaki et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2007)
CD56bright human NK cells differentiate into CD56dim cells:: Role of contact with peripheral fibroblasts
Antoni Chan et al.
JOURNAL OF IMMUNOLOGY (2007)
Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate
Donald N. Forthal et al.
JOURNAL OF IMMUNOLOGY (2007)
Association of polymorphic extracellular domains of MICA with cervical cancer in northeastern Thai population
A. Jumnainsong et al.
TISSUE ANTIGENS (2007)
Human natural killer cell deficiencies
Jordan S. Orange
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
M Yawata et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing
C Morishima et al.
HEPATOLOGY (2006)
The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest
K Sakai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The immune response during hepatitis B virus infection
Antonio Bertoletti et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance
T Hayashi et al.
CANCER RESEARCH (2006)
Characterization of CD56-/CD16+ natural killer (NK) cells:: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals
D Mavilio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo et al.
SCIENCE (2004)
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads
P Nag et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules
MI Bonaparte et al.
BLOOD (2004)
Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates
D Mavilio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
IL-21 induces both rapid maturation of human CD34(+) cell precursors towards NK cells and acquisition of surface killer Ig-like receptors
S Sivori et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Natural killer cells and their receptors
D Middleton et al.
TRANSPLANT IMMUNOLOGY (2002)
Selective depletion of CD56dim NK cell subsets and maintenance of CD56bright NK cells in treatment-naive HIV-1-seropositive individuals
R Tarazona et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2002)
Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype
HG Shilling et al.
JOURNAL OF IMMUNOLOGY (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation
J Storek et al.
BLOOD (2001)
Natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents
SD Douglas et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Share Paper
